该市场在2024年的估值为6.8665亿美元,预计到2032年将达到11.0744亿美元。
Fondaparinux市场预计在预测期内将以6.3%的年均增长率增长。
Fondaparinux市场的增长主要受到血栓栓塞疾病发病率增加、全球外科手术干预激增、先进抗凝治疗的日益普及以及持续改进的制剂和给药技术提升治疗效果和安全性的推动。
雅培实验室公司、葛兰素史克公司、德克萨斯州雷迪药厂、拜耳医疗保健公司、博扬格公司、赛诺菲和鲁宾制药是关键参与者。
该市场在2024年的估值为6.8665亿美元,预计到2032年将达到11.0744亿美元。
Fondaparinux市场预计在预测期内将以6.3%的年均增长率增长。
Fondaparinux市场的增长主要受到血栓栓塞疾病发病率增加、全球外科手术干预激增、先进抗凝治疗的日益普及以及持续改进的制剂和给药技术提升治疗效果和安全性的推动。
雅培实验室公司、葛兰素史克公司、德克萨斯州雷迪药厂、拜耳医疗保健公司、博扬格公司、赛诺菲和鲁宾制药是关键参与者。
Related Reports
The Dilated Cardiomyopathy Therapeutic Market size was estimated at USD 5,240.95 million in 2025 and is expected to reach USD 8,025.37 million by 2032, growing at a CAGR of 7.36% from 2025 to 2032.
The Divalproex Sodium Market size was estimated at USD 1,860.58 million in 2025 and is expected to reach USD 2,453.73 million by 2032, growing at a CAGR of 4.72% from 2025 to 2032.
The global somatostatin analogs market was valued at USD 7,187.5 million in 2024 and is projected to reach USD 12,349.46 million by 2032, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period.
The global respiratory disease vaccine market was valued at USD 94,579.5 million in 2024 and is projected to reach USD 102,011.14 million by 2032, expanding at a compound annual growth rate (CAGR) of 2.1% during the forecast period
The Respiratory Syncytial Virus (RSV) Therapeutics market was valued at USD 1,542.48 million in 2024 and is projected to reach USD 4,493.54 million by 2032, expanding at a strong CAGR of 14.3% during the forecast period.
Vitamin K market size was valued USD 2,448.6 Million in 2024 and is anticipated to reach USD 3,645.35 Million by 2032, at a CAGR of 5.1% during the forecast period.
The Oral Macromolecular Formulation market size was valued at USD 17.5 billion in 2025 and is projected to reach USD 24.5 billion by 2032, reflecting a CAGR of 4.9% during the forecast period.
The Ineffective Esophageal Motility Treatment market size was valued at USD 4,680 million in 2024 and is projected to reach USD 7,402.47 million by 2032, growing at a CAGR of 5.9% during the forecast period.
At Home Molecular Testing market size was valued at USD 10,809 million in 2024 and is anticipated to reach USD 16,463.2 million by 2032, growing at a CAGR of 5.4% during the forecast period.
The global OTC cough, cold, and allergy medicine market was valued at USD 23,450 million in 2024 and is projected to reach USD 32,590.02 million by 2032, expanding at a compound annual growth rate (CAGR) of 4.2% during the forecast period.
Novel Cardiovascular Drug Delivery Devices Market size was valued USD 5189 million in 2024 and is anticipated to reach USD 9322.84 million by 2032, at a CAGR of 7.6% during the forecast period.
The Small Molecule Injectable market was valued at USD 141,836 million in 2024 and is anticipated to reach USD 241,884.7 million by 2032, growing at a CAGR of 6.9% during the forecast period.
许可证选项
Report delivery within 24 to 48 hours
What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
材料科学家
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
Imre Hof
管理助理,Bekaert
深受信赖
